On March 3, 2017 Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, reported that Tito Serafini, Ph.D., President, Chief Executive Officer, and Co-­Founder, will present at the Cowen and Company 37th Annual Health Care Conference on Wednesday, March 8, 2017 at 2:00 p.m. Eastern Time at the Boston Marriott Copley Place (Press release, Atreca, MAR 3, 2017, View Source [SID1234522954]). Dr. Serafini will provide an overview of Atreca’s technologies, programs and progress.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!